Last checked at (Sharecast News) - Fevertree: Barclays upgrades to buy with a target price of 2,500p.
Taylor Wimpey: Berenberg reiterates buy with a target price of 210p.
Centamin: Berenberg reiterates buy with a target price of 133p.
Litigation Capital Management: Canaccord reiterates buy with a target price of 94p.
Helium One Global: Canaccord initiates at speculative buy with a target price of 20p.
Ultra Electronics: JP Morgan reiterates overweight with a target price of 2,500p.
Croda: JP Morgan reiterates underweight with a target price of 5,550p.
AstraZeneca: Deutsche Bank reiterates buy with a target price of 10,200p.
GSK: Deutsche Bank reiterates sell with a target price of 1,150p.
Reckitt Benckiser: Barclays reiterates overweight with a target price of 9,100p.
Cineworld: Peel Hunt downgrades to hold with a target price of 105p.
Knights: Liberum reiterates buy with a target price of 500p.
Ergomed: Numis downgrades to add with a target price of 1,330p.
Bunzl: RBC Capital Markets upgrades to sector perform with a target price of 2,270p.
14 Jan 2019 12:43
Litigation Capital Management to fund Aussie case
(Sharecast News) - Litigation financing solutions provider Litigation Capital Management entered into an agreement to provide litigation finance in relation to proceedings which were currently being undertaken in Australasia, it announced on Monday.
Read more